Steven Mayers

Steven Mayers


Personal profile


Cellular therapy is a growing area with great promise in treating many devastating diseases. I'm interested in exploring new ways to produce useful cells that can be used to improve patient outcomes. My PhD research is in developing blood cell production platforms for therapeutic applications. We're combining stem cell biology, targeted genetic engineering, and industrial biotechnology looking for new disruptive methods to produce novel medicines. This project is a collaboration between the School of Medical Sciences, Cancer Research UK, and Biotechnology Engineering. 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Master of Engineering, Engineering Red Blood Cell Progenitors to Achieve Greater Proliferative Potential, University of Toronto

1 Sept 20121 Jul 2015

Award Date: 1 Jul 2015

Bachelor of Applied Science, Chemical Engineering and Applied Chemistry, University of Toronto

1 Sept 20071 Jul 2012

Award Date: 1 Jul 2012

External positions

Associate Scientist, AstraZeneca

1 Jul 20181 Jul 2019

Research Associate, AstraZeneca

1 Jul 20151 Jul 2018

Research Beacons, Institutes and Platforms

  • Biotechnology
  • Cancer


  • Stem Cell Biology
  • Cell Therapy
  • Genetic Engineering
  • Bioprocesss Engineering
  • Biotechnology


Dive into the research topics where Steven Mayers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles